GMO argues that Japan’s equity market is undergoing a durable structural transformation driven by governance reform, improving profitability, and shareholder-focused capital allocation.
- Japanese corporates have materially improved margins, ROE, dividends, buybacks, and earnings growth over the past decade, outpacing nominal GDP growth and even U.S. earnings growth in some periods.
- Despite strong recent returns, Japanese equities still trade at roughly a 20% discount to U.S. equities on forward earnings and remain significantly cheaper on price-to-book and price-to-sales metrics.
- GMO sees the strongest opportunity in Japanese small-value equities, where roughly 40% of TOPIX companies still trade below book value, creating fertile ground for active investors and shareholder engagement.
The report’s broader thesis is that Japan is no longer merely a cyclical trade on yen weakness, but a slow-moving structural re-rating of corporate Japan itself.
Continue reading this article?
Register for free and get access to Investment Officer International:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required
Register for free and get access to Investment Officer Luxembourg:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required
